BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/30/2025 7:25:49 AM | Browse: 30 | Download: 0
Category |
Oncology |
Manuscript Type |
Minireviews |
Article Title |
Progress in the treatment of duodenal cancer: A comprehensive review
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Liang-Gong Liao, Zhi-Guo Xiong and Jun-Jie Hu |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Research Projects of Biomedical Center of Hubei Cancer Hospital |
2022SWZX07 |
the 2023-2024 Annual Scientific Research Project of Traditional Chinese Medicine from Hubei Provincial Administration of Traditional Chinese Medicine |
ZY2023Z005 |
Health Commission of Hubei Province Scientific Research Project |
WJ2023Z011 |
|
Corresponding Author |
Jun-Jie Hu, MD, Department of Gastrointestinal Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 116 Zuodaoquan South Road, Wuhan 430079, Hubei Province, China. 791462122@qq.com |
Key Words |
Duodenal cancer; Surgical resection; Chemotherapy; Targeted therapies; Immunotherapy |
Core Tip |
Duodenal cancer, a rare gastrointestinal malignancy (< 0.5/100000 incidence), requires multidisciplinary strategies. Endoscopic resection for early-stage tumors improves survival and reduces infection mortality. Advanced cases benefit from surgery and minimally invasive techniques. Chemotherapy and neoadjuvant chemoradiotherapy enhance outcomes. Targeted therapies such as erb-b2 receptor tyrosine kinase 2 (human epidermal growth factor receptor 2)/phosphatidylinositol-3-kinase inhibitors and immunotherapy show transformative potential. Molecular profiling guides precision medicine. International collaboration is critical to optimize biomarker-driven strategies and improve survival. This review integrates innovations in surgery, systemic therapy, and immunotherapy, offering a roadmap for personalized management. |
Citation |
Liao LG, Xiong ZG, Hu JJ. Progress in the treatment of duodenal cancer: A comprehensive review. World J Gastrointest Oncol 2025; In press |
 |
Received |
|
2025-02-05 04:39 |
 |
Peer-Review Started |
|
2025-02-05 04:39 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-03-25 07:10 |
 |
Revised |
|
2025-04-04 08:55 |
 |
Second Decision |
|
2025-05-30 02:43 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-05-30 07:25 |
 |
Articles in Press |
|
2025-05-30 07:25 |
 |
Publication Fee Transferred |
|
2025-04-11 04:31 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
1948-5204 (online) |
Open Access |
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345